Francesca Barone
Chief Scientific Officer · Candel Therapeutics, Inc.
- 2024
- Jul 1, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Francesca Barone files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Paul Peter Tak - $3.16M in CADL purchases and sales in the last 12 months
- Paul B. Manning - $3.00M in CADL purchases and sales in the last 12 months
- Seshu Tyagarajan - $154K in CADL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Francesca Barone?
Francesca Barone is a corporate insider, tracked as Chief Scientific Officer of Candel Therapeutics, Inc. (CADL). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Francesca Barone last file a Form 4?
The most recent primary Form 4 on record is dated 1 July 2026, one of 3 filings going back to 2024.
Has Francesca Barone been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($336K) across all tracked filings.
